Dr. Neslusan is currently Group Director of Market Access Scientific and External Strategy (MAxSES) in the U.S. Value and Evidence Scientific Engagement team at Janssen Scientific Affairs, part of Johnson & Johnson. The MAxSES Team is responsible for U.S. market access scientific strategy for medicines in early development, anticipating future market access trends. In addition, the group engages with scientific leaders and performs research to support Janssen’s health policy positions. Dr. Neslusan has over 25 years of experience in health economics, with specific expertise in data analytics, synthesis and modeling. She joined Johnson & Johnson in 2000 and held various roles with Janssen’s Global Market Access teams until 2018. Her responsibilities included developing evidence generation strategies and tactical plans as well as conducting evidence substantiation projects to optimize value assessments globally and inform stage gate decisions for a wide range of products in a variety of therapeutic areas. Prior to joining Janssen, she had research roles at the MedStat Group and the Social Security Administration’s Office of Research and Policy. She began her career in the Economics Department at Miami University in Oxford, OH. Dr. Neslusan received her B.A. in Economics from Clark University in Worcester, MA and holds both an M.A. and Ph.D. in Economics from Penn State.
